Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.

Nature communications·2026
Same author

Autoantigen mRNA-LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for Autoimmunity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Retraction Note: Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer.

Nature communications·2026
Same author

IL1RAP-expressing myeloid-stromal networks represent a therapeutic vulnerability to improve chemoimmunotherapy sensitivity in pancreatic cancer.

JCI insight·2026
Same author

MicroRNA-29a enhances and preserves stem-like CD8 T cell differentiation by regulating master epigenetic circuits of exhaustion.

bioRxiv : the preprint server for biology·2026
Same author

Amendment to Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer.

The Journal of clinical investigation·2026

Related Experiment Video

Updated: Mar 10, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.4K

Adjuvant-Enhanced mRNA Vaccines.

Lukasz Bialkowski1, Kevin Van der Jeught1, Dries Renmans1

  • 1Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Laarbeeklaan 103E, Brussels, Belgium.

Methods in Molecular Biology (Clifton, N.J.)
|December 18, 2016
PubMed
Summary

Messenger RNA (mRNA) vaccines show promise for cancer immunotherapy. This study details methods for using in vitro transcribed (IVT) mRNA to stimulate anticancer immune responses in mouse models.

Keywords:
Bioluminescence imagingCancer immunotherapyDendritic cellsElectroporationIntralymphaticIntranodalIntratumoralTherapeutic vaccinemRNA

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.1K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K

Related Experiment Videos

Last Updated: Mar 10, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.4K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.1K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K

Area of Science:

  • Molecular Biology
  • Immunology
  • Biotechnology

Background:

  • Recent advancements have significantly improved the stability and translational efficiency of in vitro transcribed (IVT) messenger RNA (mRNA).
  • Messenger RNA (mRNA) vaccines are emerging as a potent strategy in cancer immunotherapy, offering potential advantages over traditional vaccine platforms like bacteria, viruses, or cells.

Purpose of the Study:

  • To present experimental procedures for generating anticancer immune responses using IVT mRNA.
  • To evaluate the efficacy of IVT mRNA encoding specific antigens and immune-activating signals in preclinical cancer models.

Main Methods:

  • Utilizing in vitro transcription (IVT) to produce engineered mRNA molecules.
  • Designing mRNA constructs encoding tumor-associated antigens and immune-stimulatory payloads.
  • Administering IVT mRNA to various murine tumor models to elicit therapeutic immune responses.

Main Results:

  • Demonstrated the induction of specific anticancer immune responses in treated murine models.
  • Observed modulation of the tumor microenvironment through mRNA-mediated immune activation.
  • Provided a reproducible methodology for mRNA-based cancer vaccine development.

Conclusions:

  • In vitro transcribed (IVT) mRNA is a viable platform for developing novel cancer vaccines.
  • The presented experimental approach effectively stimulates anticancer immunity in preclinical settings.
  • Further development of mRNA-based immunotherapies holds significant promise for cancer treatment.